Publicació
Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.
Veure totes les publicacions
Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.